financetom
Business
financetom
/
Business
/
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
Apr 1, 2025 10:52 AM

(Reuters) -Telehealth firm Hims & Hers Health ( HIMS ) said on Monday it plans to sell Eli Lilly's ( LLY ) weight-loss drug Zepbound on its platform.

Shares of the company were up 8.5% in afternoon trading.

(Reporting by Sneha S K in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved